Fluid resuscitation in septic shock: too much, too little or just right? by John R Prowle
In their interesting observational study Smith and Perner 
[1] describe ﬂ uid resuscitation (FR) in 164 patients with 
septic shock, concluding that survival was better in 
patients receiving higher volumes over the ﬁ rst 72  h. I 
think we should be cautious, however, to conclude from 
this that more is better.
Median FR was 4.0  L over 24  h, and 7.5  L by 72  h  - 
relatively small volumes for patients with ongoing shock. 
FR volumes reported from trials performed in septic 
shock are substantially larger despite comparable illness 
severity; mean FR over 72  h was approximately 19  L in 
the Vasopressin in Septic Shock Trial (VASST) study [2], 
13 L in the study by Rivers and colleagues [3] and 16 L in 
another recent study [4]. Indeed, median FR in the high-
volume group (10.9  L at 72  h) was comparable to the 
lowest quartile, associated with the best prognosis, in the 
VASST study (16 L at 96 h) [2]. Th us, I do not believe that 
the beneﬁ t of higher-volume FR described is in conﬂ ict 
with the harm associated with larger volumes reported 
previously [2]. Similarly, median FR in the lower-volume 
group was only 4.3  L in 72  h. As FR was physician-
directed, lower-volume FR might have been indicated by 
factors like chronic cardiac failure or ﬂ uid unresponsive-
ness associated with poorer outcomes irrespective of FR; 
no evidence is provided to conclude that increasing FR in 
this group would have improved survival.
Overall, this report records excellent outcomes using 
moderate FR by recent standards. Further trials are 
needed to characterize the dose and indications for FR in 
septic shock.
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Th anks to Dr Prowle for his interest in our study. We 
agree that observations in cohort studies should be inter-
preted with caution, in particular in complex clinical 
settings such as ﬂ uid resuscitation of patients with sepsis 
in the ICU. Th e interpretation of studies in this area is 
further complicated by diﬀ erences in the reporting of 
ﬂ uid therapy. Th e types of, and indications for, ﬂ uids are 
most often not reported, so when previous trials [2-4] 
report that more than 10 L of ﬂ uid was given by day 3, we 
do not know if this ﬂ uid was given for resuscitation. In 
trials of ﬂ uid resuscitation [5] (unpublished observations 
from the 6S trial [6]), 2.5 L of other ﬂ uids were given for 
each liter of resuscitation ﬂ uid. Th e indications for giving 
other ﬂ uids may include nutrition, maintenance, ﬂ uids 
with medications and electrolytes or even to keep a drip 
open, but we do not know the details. Taken together, we 
support the notion that the controversy of ﬂ uid volume 
in septic shock may only be resolved in randomized trials 
of higher versus lower ﬂ uid volumes in these patients. 
Such trials should be top priority for the ICU research 
community.
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